MREO
Mereo BioPharma
MREO
MREO
53 hedge funds and large institutions have $84.3M invested in Mereo BioPharma in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 21 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
57% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 21
Holders
53
Holding in Top 10
–
Calls
$775K
Puts
$28K
Top Buyers
| 1 | +$7.3M | |
| 2 | +$4.69M | |
| 3 | +$4.49M | |
| 4 |
Alkeon Capital Management
New York
|
+$1.79M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$1.65M |
Top Sellers
| 1 | -$5.48M | |
| 2 | -$2.05M | |
| 3 | -$1.69M | |
| 4 |
MAM
Monaco Asset Management
Monaco
|
-$806K |
| 5 |
Citigroup
New York
|
-$799K |